Meng‐Feng Tsai - Concepedia

Author

Meng‐Feng Tsai

National Taiwan University

Also Known As

Meng-Feng Tsai, Meng-feng Tsai, MengFeng Tsai, Mengfeng Tsai, Meng‐Feng Tsai, Tsai, Meng-Feng

107

Publications

2.4K

Citations

H-Index

Concepts

All Affiliations

National Taiwan University National Taiwan University Hospital Dayeh University National Central University Far Eastern Memorial Hospital

About

Meng‐Feng Tsai is an author at National Taiwan University specializing in medicine, lung cancer, and tumor biology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	11	11	711
2	Engineering	4	4	55
3	Health Sciences	2	2	237
4	Natural Sciences	1	1	49
5	Biology	1	1	49

Meng‐Feng Tsai

Publications

2.3K

Citations

H-Index

Page 1

	Year	Citations
Tumor-Associated Macrophages: The Double-Edged Sword in Cancer Progression Jeremy J.W. Chen, Yi‐Chen Lin, Pei‐Li Yao, Journal of Clinical Oncology	2004	372
The mechanism of acquired resistance to irreversible EGFR tyrosine kinase inhibitor-afatinib in lung adenocarcinoma patients Shang‐Gin Wu, Yinan Liu, Meng‐Feng Tsai, Oncotarget	2016	234
Curcumin Inhibits Lung Cancer Cell Invasion and Metastasis through the Tumor Suppressor HLJ1 Huei‐Wen Chen, Jen‐Yi Lee, Jiying Huang, Cancer Research	2008	219
Epidermal growth factor receptor mutations in needle biopsy/aspiration samples predict response to gefitinib therapy and survival of patients with advanced nonsmall cell lung cancer Jin‐Yuan Shih, Chien‐Hung Gow, Chong‐Jen Yu, International Journal of Cancer	2005	172
ALDH-positive lung cancer stem cells confer resistance to epidermal growth factor receptor tyrosine kinase inhibitors Cheng-Po Huang, Meng‐Feng Tsai, Tzu‐Hua Chang, Cancer Letters OncologyMedicineReceptor Tyrosine KinaseBronchial NeoplasmCancer Biology	2012	165
Survival of lung adenocarcinoma patients with malignant pleural effusion Shang‐Gin Wu, Chong‐Jen Yu, Meng‐Feng Tsai, European Respiratory Journal	2012	93
EML4-ALK Translocation Predicts Better Outcome in Lung Adenocarcinoma Patients with Wild-Type EGFR Shang‐Gin Wu, Yao-Wen Kuo, Yih‐Leong Chang, Journal of Thoracic Oncology Tumor BiologyOncologyMedicineLung Adenocarcinoma PatientsPathology	2011	90
IL-8 confers resistance to EGFR inhibitors by inducing stem cell properties in lung cancer Yinan Liu, Tzu‐Hua Chang, Meng‐Feng Tsai, Oncotarget	2015	86
Clinical and the Prognostic Characteristics of Lung Adenocarcinoma Patients with ROS1 Fusion in Comparison with Other Driver Mutations in East Asian Populations Yen‐Fu Chen, Min‐Shu Hsieh, Shang‐Gin Wu, Journal of Thoracic Oncology Ros1 FusionOncologyEast Asian PopulationsMedicineLung Adenocarcinoma Patients	2014	81
Good Response to Gefitinib in Lung Adenocarcinoma of Complex Epidermal Growth Factor Receptor (<i>EGFR</i>) Mutations with the Classical Mutation Pattern Shang‐Gin Wu, Yih‐Leong Chang, Y. L. Hsu, The Oncologist	2008	76

Page 1